SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-322571
Filing Date
2018-11-08
Accepted
2018-11-08 16:16:37
Documents
3
Period of Report
2018-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d538920d8k.htm 8-K 16311
2 EX-99.1 d538920dex991.htm EX-99.1 48058
3 GRAPHIC g538920g22g03.jpg GRAPHIC 3106
  Complete submission text file 0001193125-18-322571.txt   69901
Mailing Address 10614 SCIENCE CENTER DRIVE SAN DIEGO CA 92121
Business Address 10614 SCIENCE CENTER DRIVE SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35670 | Film No.: 181169876
SIC: 2834 Pharmaceutical Preparations